INTELLIGENT BIO SOLUTIONS INC. short interest in 2024
In 2024, INTELLIGENT BIO SOLUTIONS INC.'s disclosed short interest ran from 6.53% of shares outstanding on 15 Feb 2024 to 10.06% on 31 Dec 2024, a change of +3.53 percentage points. The year's high was 13.29% on 15 Nov 2024 and its low 1.17% on 31 May 2024, averaging 5.86% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.38 days on 31 Oct 2024. Full history: INTELLIGENT BIO SOLUTIONS INC..
Cite this page
By year: 2021 · 2022 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 6.53% (15 Feb 2024)
- End of year
- 10.06% (31 Dec 2024)
- Change
- +3.53 pp
- High
- 13.29% (15 Nov 2024)
- Low
- 1.17% (31 May 2024)
- Average
- 5.86%
- Highest days to cover
- 6.38 (31 Oct 2024)
- SEC filings marked
- 12
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Feb 2024 | 6.53% | 1.00 | results (8-K), 10-Q filed, results (8-K) |
| 15 Mar 2024 | 4.24% | 1.00 | |
| 28 Mar 2024 | 3.33% | 1.28 | |
| 15 Apr 2024 | 3.42% | 1.21 | |
| 30 Apr 2024 | 4.83% | 1.60 | results (8-K) |
| 15 May 2024 | 2.52% | 1.01 | 10-Q filed, results (8-K) |
| 31 May 2024 | 1.17% | 1.00 | |
| 14 Jun 2024 | 2.89% | 1.37 | |
| 28 Jun 2024 | 2.80% | 2.06 | |
| 15 Jul 2024 | 2.42% | 3.05 | |
| 31 Jul 2024 | 3.38% | 1.00 | |
| 15 Aug 2024 | 2.74% | 1.93 | |
| 30 Aug 2024 | 5.45% | 1.00 | |
| 30 Sep 2024 | 7.00% | 1.00 | results (8-K), 10-K filed, results (8-K) |
| 15 Oct 2024 | 8.69% | 3.12 | |
| 31 Oct 2024 | 9.90% | 6.38 | results (8-K) |
| 15 Nov 2024 | 13.29% | 3.04 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 11.96% | 3.12 | |
| 13 Dec 2024 | 10.60% | 5.41 | |
| 31 Dec 2024 | 10.06% | 3.34 |
See also: INTELLIGENT BIO SOLUTIONS INC.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.